Pharmacist Integration to Support Continuous Glucose Monitoring Initiation: A Collaborative, Patient-Centered Approach
Journal of Pharmacy Practice · 2026
DOI: 10.1177/08971900251327078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy Practice, 2026. Verfasst von James Thurston und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, New York-Presbyterian Hospital, New York, NY, USA. Hauptthemen laut MEDLINE: Pharmacists, Blood Glucose Self-Monitoring, Patient-Centered Care, Diabetes Mellitus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Objective
The development of continuous glucose monitoring (CGM) has allowed for improved glycemic control among patients with diabetes. Clinical pharmacists possess medication expertise and can provide support for increased CGM utilization through device education and affordability assistance, but there is limited evidence evaluating the effectiveness of clinical pharmacist-assisted CGM initiation. The objective of this study was to examine how clinical pharmacist-assisted CGM implementation can impact glycemic control for patients with diabetes.
Methods
This is a retrospective pre-post study that evaluated change in A1c among patients who were assisted with CGM device implementation by a clinical pharmacist between January 1, 2019, and December 31, 2023. The primary outcome of this study was change in A1c from baseline (prior to CGM initiation) to the next subsequent A1c following CGM initiation. The study team also investigated change in A1c among a subgroup of patients followed independently by clinical pharmacists practicing under a collaborative drug therapy management (CDTM) agreement.
Results
Pharmacist-assisted CGM initiation led to a statically significant decrease in mean A1c of −0.71 (CI 95% 0.41-1.00, P < 0.001) across all patients. Within the CDTM subgroup, the mean A1c difference was −1.60 (CI 95% 0.64-2.55, P = 0.002) while in the non-CDTM subgroup, the mean A1c difference was −0.50 (CI 95% 0.22-0.78, P < 0.001).
Conclusions
Clinical pharmacists are effective at helping patients with diabetes reduce their A1c through assisting with CGM initiation, education, and follow-up. Among patients included in this study, those followed by pharmacists practicing under CDTM agreements saw the greatest amount of A1c reduction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, New York-Presbyterian Hospital, New York, NY, USA.
- Department of Medicine, NewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY, USA.
ORCID-Profile: James Thurston, Hanlin Li
Zitieren
APA
Thurston, J., Li, H., Rajan, M., Baratt, Y., Bradley, A., & Pelzman, F. (2026). Pharmacist Integration to Support Continuous Glucose Monitoring Initiation: A Collaborative, Patient-Centered Approach. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900251327078
Vancouver
Thurston J, Li H, Rajan M, Baratt Y, Bradley A, Pelzman F. Pharmacist Integration to Support Continuous Glucose Monitoring Initiation: A Collaborative, Patient-Centered Approach. Journal of Pharmacy Practice. 2026. doi:10.1177/08971900251327078
BibTeX
@article{Thurston2026,
author = {Thurston, James and Li, Hanlin and Rajan, Mangala and Baratt, Yuliya and Bradley, Amber and Pelzman, Fred},
title = {Pharmacist Integration to Support Continuous Glucose Monitoring Initiation: A Collaborative, Patient-Centered Approach},
journal = {Journal of Pharmacy Practice},
year = {2026},
doi = {10.1177/08971900251327078}
}
EUVIMED